Basel Medical Group Ltd (BMGL) Income Statement
BMGL FY2025 at a glance
Fiscal year ended June 30, 2025 · Singapore dollarsBMGL revenue and net income
Where BMGL's revenue goes
FY2025Each bar shows an amount and its share of revenue. BMGL kept −106.8% of revenue as net income.
BMGL profit margins
BMGL growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +12.6% | — | — | — |
| Gross profit | +12.7% | — | — | — |
| Operating income | −199.4% | — | — | — |
| Net income | −683.2% | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BMGL income statement in Singapore dollars
| FY2025 | FY2024 | |
|---|---|---|
| Revenue | S$11.3M | S$10.1M |
| Cost of revenue | S$2.5M | S$2.2M |
| Gross profit | S$8.8M | S$7.8M |
| Sales, general & admin | S$6.5M | S$3.6M |
| Total operating expenses | S$11.0M | S$5.6M |
| Operating income | −S$2.2M | S$2.2M |
| Interest income | S$83,267 | S$0 |
| Interest expense | S$203,948 | S$176,238 |
| Income before taxes | −S$12.5M | S$2.4M |
| Income taxes | −S$417,393 | S$331,761 |
| Net income | −S$12.1M | S$2.1M |
| EBITDA | −S$11.1M | S$3.1M |
| Gross margin | 77.7% | 77.6% |
| Operating margin | −19.3% | 21.8% |
| Net margin | −106.8% | 20.6% |
| Mar '26 | Sep '25 | |
|---|---|---|
| Revenue | S$8.2M | S$6.1M |
| Cost of revenue | S$9.2M | S$5.4M |
| Gross profit | −S$983,322 | S$644,320 |
| Total operating expenses | S$1.9M | S$2.3M |
| Operating income | −S$2.9M | −S$1.6M |
| Interest expense | S$215,074 | S$102,416 |
| Income before taxes | S$335,237 | −S$10.3M |
| Income taxes | S$175,306 | −S$402,413 |
| Net income | S$268,443 | −S$9.9M |
| EBITDA | −S$860,601 | −S$815,394 |
| Gross margin | −11.9% | 10.6% |
| Operating margin | −35.3% | −26.7% |
| Net margin | 3.3% | −164.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in Singapore dollars as reported in BMGL's financial statements (latest annual report filed November 18, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BMGL financial results
In fiscal year 2025 (ended June 30, 2025), Basel Medical reported revenue of S$11.3 million, up 12.6% from the year before. It had a net loss of S$12.1 million, a net profit margin of −106.8%. Figures are in Singapore dollars, the currency of its financial statements.
See the BMGL stock overview for the latest quote and news, or the BMGL chart for price history and technical indicators.
BMGL income statement FAQ
What is Basel Medical's annual revenue?
Basel Medical reported total revenue of S$11.3 million for fiscal year 2025, which ended on June 30, 2025. That was up 12.6% from S$10.1 million the previous year.
Is Basel Medical profitable?
No. Basel Medical reported a net loss of S$12.1 million in fiscal 2025, a net profit margin of −106.8%; its operating margin was −19.3%.
What is Basel Medical's gross margin?
Basel Medical's gross margin was 77.7% in fiscal 2025: for every $100 of revenue, Basel Medical kept $78 after the direct cost of its products and services.
When does Basel Medical's fiscal year end?
Basel Medical's fiscal year ends in June. The latest annual report covers the year ended June 30, 2025 and was filed on November 18, 2025.